Last reviewed · How we verify
Nocardiosis
Approved treatments
- Azo Gantanol · Pfizer
- Azo Gantrisin · Alra
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nocardiosis patent landscape — cliff calendar, originator estates, attackable patents
- Nocardiosis treatment landscape brief
- Nocardiosis treatment updates RSS
Frequently asked questions about Nocardiosis
What drugs treat Nocardiosis?
Tracked treatments include Azo Gantanol, Azo Gantrisin.
What is the treatment for Nocardiosis?
Standard treatment for Nocardiosis includes Azo Gantanol, Azo Gantrisin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nocardiosis patent cliff · Nocardiosis CI report
- Treatment: Azo Gantanol · Pfizer
- Treatment: Azo Gantrisin · Alra
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing